Am J Transplant, Volume 19, Suppl 3 Archives - Page 201 of 214 - ATC Abstracts

2019 American Transplant Congress
Evaluation of Rabbit Antithymocyte Globulin (rATG) Dosing and Incidence of Opportunistic Viral Infections in Kidney Transplant Recipients Using Tacrolimus (TAC), Mycophenolate (MPA) and Steroid Free Maintenance Immunosuppression
L. Von Stein, A. Leino, R. Amer, T. Pesavento, H. Winters
The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: There is limited literature evaluating rATG dosing and incidence of infection with TAC/MPA and early steroid withdrawal. This study evaluates rATG dosing and overall…
2019 American Transplant Congress
Incidence of Viral Infections in Kidney Transplant Recipients with Alemtuzumab or Rabbit Antithymocyte Globulin Induction
A. Brueckner¹, C. Truong¹, E. Yanqui¹, R. Baliga², L. Bowman¹
¹Tampa General Hospital, Tampa, FL, ²Florida Kidney Physicians, Tampa, FL
*Purpose: Monoclonal antibody therapy causes profound and sustained lymphocyte depletion thus increasing the risk of viral infections. While studies exist evaluating the outcomes of alemtuzumab…
2019 American Transplant Congress
Long-Term Outcomes of Elderly Living Donors: A Nationwide Population-Based Study
H. Yoon¹, Y. Kim², S. Shin¹, J. Ahn³, C. Yang¹, B. Chung¹
¹-The Catholic University of Korea, -Seoul, Korea, Republic of, ²Yonsei University Wonju College of Medicine, Wonju, Korea, Republic of, ³Department of Information & Statistics, Yonsei University, Wonju, Korea, Republic of
*Purpose: The organ shortage for kidney transplantation has increased the demand for living kidney donors, and elderly donors (> 60-years-old) have become more common. Long-term…
2019 American Transplant Congress
Facilitators and Barriers to Implementing the Live Donor Champion Program
A. D. Love¹, D. R. Helfer¹, S. Rasmussen¹, M. Johnson¹, J. M. Konel¹, J. R. Wellen², S. M. Nazarian³, E. King¹, D. L. Segev¹, T. Hwee¹, A. M. Cameron¹, M. L. Henderson¹, E. J. Gordon⁴, J. M. Garonzik Wang¹
¹Surgery, Johns Hopkins University, Baltimore, MD, ²Abdominal Transplant Surgery, Washington University School of Medicine, St. Louis, MO, ³Surgery, Penn Transplant Institute, Philadelphia, PA, ⁴Surgery, Northwestern Feinberg School of Medicine, Chicago, IL
*Purpose: The Live Donor Champion (LDC) Program is an intervention designed to increase kidney transplant candidate knowledge about living donor kidney transplantation (LDKT) and ability…
2019 American Transplant Congress
Correlates of Surgical Difficulty and Post-Operative Complications in Living Donor Kidney Procurement
B. I. Shaw¹, F. R. Schwartz², F. Vernucci², F. Rigiroli², F. Gonzalez², R. Lerebours³, A. S. Rege¹, D. Vikraman¹, D. Marin², K. V. Ravindra¹
¹Surgery, Duke University, Durham, NC, ²Radiology, Duke University, Durham, NC, ³Biostatistics, Duke University, Durham, NC
*Purpose: Living donor kidney donation is essential for decreasing waitlists for kidney transplantation. Though donor nephrectomy is a standard operation, there is a paucity of…
2019 American Transplant Congress
Distribution And Outcomes Of Donor Right Kidneys In A National Paired Kidney Exchange Program
G. Roll¹, W. Irish², M. Cooper³, M. Ronin⁴, G. Hil⁵, A. D. Waterman⁶, D. B. Leeser²
¹UCSF, San Francisco, CA, ²ECU, Greenville, NC, ³Georgetown Univ, Washington, DC, ⁴NKR, Babylon, CA, ⁵NKR, Babylon, NY, ⁶UCLA and Terasaki Research Institute, Los Angeles, CA
*Purpose: Left living donor kidneys for transplant (txp) are preferred to right living donor kidneys for longer renal vein length which decreases technical difficulty of…
2019 American Transplant Congress
Redefining Cirrhotic Cardiomyopathy; A Shifting Paradigm
M. J. Izzy¹, M. Angirekula², M. Leise², A. Allen², K. Watt²
¹Gastroenterology and Hepatology, Vanderbilt University Medical Center, Nashville, TN, ²Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN
*Purpose: Diastolic dysfunction (DD) is the hallmark of cirrhotic cardiomyopathy (CCM) for which criteria were established in 2005. Based on those criteria, the prevalence of…
2019 American Transplant Congress
Five Years after Right Hepatectomy for Living Liver Donation: Donor State of Health
D. P. Hoyer, E. Malamutmann, G. Bagias, A. Oezcelik
General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany
*Purpose: Of utmost importance in living liver donation is the avoidance of postoperative complications and reduction of quality of life of the donor.*Methods: Inclusion criteria…
2019 American Transplant Congress
Ligation of the Proximal Splenic Vein to Keep Adequate Portal Flow in Patients with Large Splenorenal Shunts during Living Donor Liver Transplantation
C. Cheng
Department of General Surgery, Chang Gung Memorial Hospital at Linkou, Kwei-Shan Township, Taoyuan, Taiwan
*Purpose: Adequate graft portal venous flow is essential for the rapid regeneration of partial grafts during living donor liver transplantation (LDLT). Large splenorenal shunts (SRS)…
2019 American Transplant Congress
Improving Pre-Kidney Transplantion Laboratory Utilization in an Era of Increasing Waitlist Size
G. K. Mahowald¹, B. Kimball², N. Elias², E. Heher³, T. Girouard¹, S. L. Saidman¹, V. Pattanayak¹
¹Pathology, Massachusetts General Hospital, Boston, MA, ²Transplant Surgery, Massachusetts General Hospital, Boston, MA, ³Nephrology, Massachusetts General Hospital, Boston, MA
*Purpose: Beginning on March 25, 2015, our institution’s kidney transplant program has implemented a “readiness” protocol, whereby patients are listed after limited workup and comprehensive…